Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
1.0 |
High Similarity |
NPD9133 |
Approved |
0.9531 |
High Similarity |
NPD9628 |
Approved |
0.9466 |
High Similarity |
NPD9183 |
Clinical (unspecified phase) |
0.9318 |
High Similarity |
NPD1451 |
Approved |
0.9037 |
High Similarity |
NPD9627 |
Approved |
0.8828 |
High Similarity |
NPD300 |
Approved |
0.8472 |
Intermediate Similarity |
NPD2180 |
Approved |
0.8403 |
Intermediate Similarity |
NPD1731 |
Clinical (unspecified phase) |
0.8356 |
Intermediate Similarity |
NPD3697 |
Discontinued |
0.8356 |
Intermediate Similarity |
NPD2604 |
Approved |
0.8333 |
Intermediate Similarity |
NPD875 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD3130 |
Discontinued |
0.8028 |
Intermediate Similarity |
NPD5342 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD3108 |
Clinical (unspecified phase) |
0.7769 |
Intermediate Similarity |
NPD9132 |
Discontinued |
0.7658 |
Intermediate Similarity |
NPD3105 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD8862 |
Approved |
0.76 |
Intermediate Similarity |
NPD8861 |
Approved |
0.76 |
Intermediate Similarity |
NPD8859 |
Approved |
0.7436 |
Intermediate Similarity |
NPD5768 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD566 |
Approved |
0.7181 |
Intermediate Similarity |
NPD568 |
Approved |
0.7181 |
Intermediate Similarity |
NPD567 |
Approved |
0.7067 |
Intermediate Similarity |
NPD3706 |
Clinical (unspecified phase) |
0.695 |
Remote Similarity |
NPD1389 |
Clinical (unspecified phase) |
0.695 |
Remote Similarity |
NPD1388 |
Phase 1 |
0.695 |
Remote Similarity |
NPD1390 |
Phase 1 |
0.6944 |
Remote Similarity |
NPD9081 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD1807 |
Clinical (unspecified phase) |
0.6631 |
Remote Similarity |
NPD8261 |
Discontinued |
0.6612 |
Remote Similarity |
NPD3497 |
Clinical (unspecified phase) |
0.6543 |
Remote Similarity |
NPD7465 |
Suspended |
0.649 |
Remote Similarity |
NPD576 |
Discontinued |
0.6478 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.6409 |
Remote Similarity |
NPD8641 |
Approved |
0.623 |
Remote Similarity |
NPD8113 |
Phase 2 |
0.6221 |
Remote Similarity |
NPD3347 |
Clinical (unspecified phase) |
0.6194 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.6185 |
Remote Similarity |
NPD1037 |
Clinical (unspecified phase) |
0.6173 |
Remote Similarity |
NPD8271 |
Discontinued |
0.6139 |
Remote Similarity |
NPD582 |
Approved |
0.6139 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.6139 |
Remote Similarity |
NPD8292 |
Phase 2 |
0.6129 |
Remote Similarity |
NPD1249 |
Clinical (unspecified phase) |
0.6066 |
Remote Similarity |
NPD459 |
Clinical (unspecified phase) |
0.6065 |
Remote Similarity |
NPD1120 |
Approved |
0.6065 |
Remote Similarity |
NPD1121 |
Approved |
0.6056 |
Remote Similarity |
NPD7245 |
Approved |
0.6056 |
Remote Similarity |
NPD7246 |
Clinical (unspecified phase) |
0.6039 |
Remote Similarity |
NPD209 |
Clinical (unspecified phase) |
0.6037 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.6032 |
Remote Similarity |
NPD8629 |
Discontinued |
0.6012 |
Remote Similarity |
NPD276 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.5976 |
Remote Similarity |
NPD1335 |
Approved |
0.5964 |
Remote Similarity |
NPD1029 |
Clinical (unspecified phase) |
0.5964 |
Remote Similarity |
NPD1030 |
Approved |
0.5964 |
Remote Similarity |
NPD1027 |
Approved |
0.5959 |
Remote Similarity |
NPD9360 |
Approved |
0.5942 |
Remote Similarity |
NPD8837 |
Clinical (unspecified phase) |
0.5915 |
Remote Similarity |
NPD8954 |
Approved |
0.5915 |
Remote Similarity |
NPD8955 |
Approved |
0.5914 |
Remote Similarity |
NPD460 |
Discontinued |
0.5912 |
Remote Similarity |
NPD1118 |
Discontinued |
0.5876 |
Remote Similarity |
NPD7834 |
Approved |
0.5876 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.5875 |
Remote Similarity |
NPD1431 |
Approved |
0.5875 |
Remote Similarity |
NPD1430 |
Approved |
0.5871 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.5865 |
Remote Similarity |
NPD8119 |
Discontinued |
0.5855 |
Remote Similarity |
NPD515 |
Phase 1 |
0.5854 |
Remote Similarity |
NPD775 |
Approved |
0.5846 |
Remote Similarity |
NPD7981 |
Discontinued |
0.5839 |
Remote Similarity |
NPD2618 |
Phase 1 |
0.5817 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.5799 |
Remote Similarity |
NPD1303 |
Phase 1 |
0.5799 |
Remote Similarity |
NPD695 |
Discontinued |
0.5769 |
Remote Similarity |
NPD2138 |
Approved |
0.5769 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.5769 |
Remote Similarity |
NPD2137 |
Approved |
0.5765 |
Remote Similarity |
NPD3405 |
Phase 3 |
0.5753 |
Remote Similarity |
NPD757 |
Phase 3 |
0.5743 |
Remote Similarity |
NPD237 |
Clinical (unspecified phase) |
0.574 |
Remote Similarity |
NPD510 |
Phase 1 |
0.5731 |
Remote Similarity |
NPD1290 |
Phase 2 |
0.573 |
Remote Similarity |
NPD2009 |
Clinical (unspecified phase) |
0.5729 |
Remote Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.5724 |
Remote Similarity |
NPD579 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD340 |
Approved |
0.5714 |
Remote Similarity |
NPD8186 |
Phase 1 |
0.5714 |
Remote Similarity |
NPD8185 |
Discontinued |
0.5714 |
Remote Similarity |
NPD341 |
Approved |
0.5705 |
Remote Similarity |
NPD76 |
Approved |
0.5705 |
Remote Similarity |
NPD9288 |
Approved |
0.5705 |
Remote Similarity |
NPD307 |
Approved |
0.5705 |
Remote Similarity |
NPD9292 |
Approved |
0.5705 |
Remote Similarity |
NPD9289 |
Approved |
0.57 |
Remote Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.5698 |
Remote Similarity |
NPD482 |
Approved |
0.5697 |
Remote Similarity |
NPD9724 |
Phase 1 |
0.5696 |
Remote Similarity |
NPD194 |
Clinical (unspecified phase) |
0.5686 |
Remote Similarity |
NPD245 |
Suspended |
0.5676 |
Remote Similarity |
NPD1368 |
Approved |
0.5665 |
Remote Similarity |
NPD1042 |
Clinical (unspecified phase) |
0.566 |
Remote Similarity |
NPD252 |
Clinical (unspecified phase) |
0.5657 |
Remote Similarity |
NPD6545 |
Clinical (unspecified phase) |
0.5652 |
Remote Similarity |
NPD2096 |
Phase 2 |
0.5652 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.5652 |
Remote Similarity |
NPD2091 |
Phase 2 |
0.5652 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.5644 |
Remote Similarity |
NPD3353 |
Approved |
0.5641 |
Remote Similarity |
NPD9632 |
Phase 3 |
0.5637 |
Remote Similarity |
NPD8105 |
Discontinued |
0.5625 |
Remote Similarity |
NPD8075 |
Discontinued |
0.5622 |
Remote Similarity |
NPD7557 |
Clinical (unspecified phase) |
0.5616 |
Remote Similarity |
NPD7980 |
Clinical (unspecified phase) |
0.5613 |
Remote Similarity |
NPD1355 |
Clinical (unspecified phase) |
0.5613 |
Remote Similarity |
NPD1354 |
Approved |
0.5613 |
Remote Similarity |
NPD1356 |
Approved |
0.5608 |
Remote Similarity |
NPD996 |
Phase 2 |
0.5608 |
Remote Similarity |
NPD994 |
Phase 2 |
0.5605 |
Remote Similarity |
NPD9650 |
Phase 3 |
0.5602
|
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |